FDA Inspection 817537 — Acclarent, Inc.

Acclarent, Inc. — FEI 3005172759

The FDA completed an inspection of Acclarent, Inc. on February 22, 2013 in Irvine, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
February 22, 2013
Fiscal Year
2013
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Irvine, CA (United States)

Citations

IDCFRDescription
310121 CFR 820.30(g)Design validation- Lack of or inadequate procedures
419121 CFR 806.10(a)(1)Report of risk to health